Skip to content
Heart icon (animated) heart icon (static)
Our Stories
Explore more Johnson & Johnson sites:
Switzerland
Share
In March 2021, Johnson & Johnson Pvt. Ltd. was recognized as a Best Employer in India, as part of the Kincentric Best Employers global certification, a program that measures and recognizes leading employers who capture the full power of their people to drive results and create sustainable competitive advantage.
COVID-19 has caused significant disruptions to tuberculosis (TB) services in India – which has the highest burden of TB cases globally. Not only may people with TB be uniquely vulnerable to severe complications from COVID-19, if infected – but the pandemic has also disrupted already-stretched systems of delivering TB care, and lockdowns have made much-needed social support increasingly difficult to come by.
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
On the latest episode of "The Road to a Vaccine," host Lisa Ling delves into the effects of the pandemic on kids. We sat down with one of the guests, Vikram Patel, a professor at Harvard Medical School, to find out the most pressing questions on his mind.
A close-up view of a microscope and a hand
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
India accounts for more than a quarter of the global burden of tuberculosis (TB), and for this reason is often called the TB capital of the world. 1 In a recent report titled, India Health of Nation’s States, TB was listed as one of the top ten causes of death in the country. 2 In recent years, the rapid emergence of multidrug-resistant TB (MDR-TB) – which does not respond to at least two of the most commonly used TB treatments – has made the situation worse.
Two rising star entrepreneurs who shadowed executives at Johnson & Johnson share how they’re using what they learned back home in India.
The company has once again been recognized for its commitment to employees, innovation and the health and well-being of people around the world.
Back to top